[1] 诸兴桂,冉华树.肺炎支原体DNA与血清炎性因子检测在支原体肺炎患儿中的应用[J].国际检验医学杂志,2014,12(12):1638-1640. [2] Lee E, Cho HJ, Hong SJ, et al. Prevalence and clinical manifestations of macrolide resistant Mycoplasma pneumoniaepneumonia in Korean children[J]. Korean J Pediatr, 2017, 60(5):151-157. [3] 中华医学会儿科学分会呼吸学组. 儿童肺炎支原体肺炎诊治专家共识(2015年版)[J]. 中华实用儿科临床杂志, 2015, 30(17):1304-1308. [4] 胡皓夫.重症肺炎的诊断与治疗[J].实用儿科临床杂志, 2008, 23(6): 408-410. [5] Singh P, Seth A. Mycoplasma pneumoniae, A Tale of 50 Years[J]. Indian Pediatr, 2016, 53 (2):147-148. [6] ZHANG Y, ZHOU Y, LI S, et al. The clinical characteristics and predictors of refractory mycoplasma pneumoniae pneumonia in children[J]. PLoS One, 2016, 11(5): e0156465. [7] Umbro I, Gentile G, Tintif F, et al. Recent advances in pathophysiology and biomarkers of sepsis-induced acute kidney injury[J]. J Infect, 2016, 72(2):131-142. [8] Edelstein I, Rachina S, Touati A, et al. Mycoplasma pneumoniae Monoclonal P1 Type 2c Outbreak, Russia, 2013[J]. Emerg Infect Dis, 2016, 22 (2):348-350. [9] Litovsky RY, Gordon K. Bilateral cochlear implants in children: Effects of auditory experience and deprivation on auditory perception[J]. Hear Res, 2016, 338:76-87.